After a change in screening guidelines, the incidence increased across the state, surpassing the national trend. A new study ...

She noted the survival benefit with the combination was achieved even though 38% of patients in the enzalutamide-alone arm ...

Dr. Barry W. Goy explains how to interpret PSA levels after prostate cancer treatment and how to manage recurrence based on ...

High prostate-specific antigen levels before High-Intensity Focused Ultrasound were linked to higher recurrence and treatment failure in intermediate-risk prostate cancer.

Interrupting signals exchanged between tumors and the nervous system could become a critical pillar of cancer care ...

The American Cancer Society's chief scientific officer outlines the group's research agenda, including a new project in ...

Quality of life, treatment impact and duration, and the importance of individualized therapy are at the center of ...

Herbie And Nicole Wertheim were married for 55 years. Now Nicole claims her ex forged her signature and removed her access to $250 million in charitable funds.

Having raised more than $1 million toward cancer research over the past nine years, the tournament is on the road to raising ...

After re-staging patients, ideally with PSMA-PET, and performing a biopsy to confirm the recurrence and stratify them into risk categories, it is time to discuss local salvage treatment. Options ...

The primary study objective was to evaluate the prognostic value of post-therapeutic SPECT by RECIP 1.0 for overall survival.

Darolutamide may offer greater benefits than enzalutamide or apalutamide for Black and White patients with non-metastatic ...